Multiple Myeloma

Low-dose cyclophosphamide with GM-CSF is effective and has low toxicity

Published in Cancer Weekly, May 27th, 2003

Low dose cyclophosphamide with granulocyte colony stimulating factor is a very good treatment for multiple myeloma.

"Cyclophosphamide (CY) combined with granulocyte colony-stimulating factor (G-CSF) is commonly used to mobilize blood progenitor cells to support high dose therapy in patients with multiple myeloma (MM). The optimal dose of CY in this setting is unknown.

"We have retrospectively analyzed mobilization efficiency and need for supportive care in 57 patients with newly diagnosed myeloma, previously treated with VAD±local radiotherapy," scientists writing in the journal Bone Marrow Transplantation report.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2003-05-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry